Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review

Creative Commons License

Yıldırım R., Üsküdar Cansu D., Arık D., Şaylısoy S., Korkmaz C.

RHEUMATOLOGY INTERNATIONAL, cilt.41, sa.10, ss.1845-1853, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 41 Sayı: 10
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1007/s00296-021-04822-6
  • Dergi Adı: RHEUMATOLOGY INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.1845-1853
  • Anahtar Kelimeler: Rheumatoid arthritis, Anti-tumor necrosis factor, Meningitis, Aseptic meningitis, Leptomeningitis, Pachymeningitis, ALPHA THERAPY, PACHYMENINGITIS, DEMYELINATION, ADALIMUMAB
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.